USPTO serial 77789409
ACCEL CLINICAL SERVICES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 13, 2010
- Examiner
- PILARO, MARK F
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with ACCEL CLINICAL SERVICES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Clinical Research Holdings, LLC
Lake Mary, FL
Clinical Research Holdings, LLC
Kansas City, MO
Clinical Research Holdings, LLC
Kansas City, MO
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark A. Wright
Mark A. Wright McLane Middleton, P.A.900 Elm St., P.O. Box 326Manchester, NH 03105-0326United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL RESEARCH AND CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, PRE-STUDY DOCUMENT COLLECTION AND REVIEW, SITE SELECTION, VISITS AND AUDITS, SITE COMPLIANCE, PROJECT TRACKING AND MONITORING REPORTS, NEGOTIATION AND ADMINISTRATION OF INVESTIGATOR GRANTS AND CLINICAL TRIAL BUDGETS AND CONTRACTS, FINANCIAL AND MANAGEMENT ACCOUNTING, DISTRIBUTION, COORDINATION AND TRACKING OF CLINICAL TRIAL PRODUCTS AND MATERIALS, REGULATORY DOCUMENT PROCESSING, LABORATORY SELECTION AND COORDINATION; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, MANAGING SITE AND STUDY-SPECIFIC SUBJECT RECRUITMENT STRATEGIES AND PROGRAMS IN THE NATURE OF CONTINGENCY STRATEGIES AND SOLUTIONS TO ADDRESS SPECIFIC PROJECT CHALLENGES; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, MANAGING THE DEVELOPMENT OF ALL STUDY RELATED DOCUMENTS AND MATERIALS IN THE NATURE OF STUDY PROTOCOLS, CONTRACTS, BUDGETS, AMENDMENTS, PAPER AND ELECTRONIC CASE REPORT FORMS, INFORMED CONSENT FORMS, SAFETY NARRATIVES, PRESENTATION POSTERS, AND TRAINING MANUALS; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, MANAGING ALL ASPECTS OF STUDY, DRUG RECONCILIATION, AND INVENTORY AND DISTRIBUTION REPORTS, MANAGING ALL ASPECTS OF CLINICAL TRIALS, NAMELY, MANAGING INVESTIGATORS, COORDINATORS, MONITORS, TECHNICIANS, AND PARTICIPANTS, ETHICAL REVIEWS, INVESTIGATOR MEETINGS, DATABASES, STATISTICAL ANALYSES AND REPORTING, RANDOMIZATION LOGISTICS, RECRUITMENT OF INVESTIGATORS, COORDINATORS, MONITORS, TECHNICIANS AND PARTICIPANTS; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PHASE ONE THROUGH PHASE FOUR ADMINISTRATION OF CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, THE ADMINISTRATION OF PROTOCOLS INVOLVING VOLUNTEER RESEARCH PATIENTS AND THE RECRUITING OF SUCH VOLUNTEER RESEARCH PATIENTS; PROVIDING DATA MANAGEMENT SERVICES IN THE MEDICAL, PHARMACEUTICAL AND BIOTECHNOLOGICAL FIELD | ACTIVE | Aug 10, 2006 |
| 041 | PROVIDING TRAINING IN THE FIELD OF CLINICAL TRIALS AND CLINICAL TRIAL MANAGEMENT FOR THE PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIES | ACTIVE | Aug 10, 2006 |
| 042 | MEDICAL AND SCIENTIFIC RESEARCH CONSULTING REGARDING PRECLINICAL TO PHASE FOUR CLINICAL TRIALS; PROVIDING QUALITY ASSURANCE SERVICES IN THE PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIES | ACTIVE | Aug 10, 2006 |
| 045 | REGULATORY AFFAIRS, NAMELY, REVIEWING STANDARDS AND PRACTICES TO ASSURE COMPLIANCE WITH CLINICAL TRIAL LAWS AND REGULATIONS | ACTIVE | Aug 1, 2006 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Clinical Research Holdings, LLC
- Other trademarks owned by Clinical Research Holdings, LLC
- Other trademarks owned by Clinical Research Holdings, LLC
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named ACCEL CLINICAL SERVICES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 29, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 29, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 29, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 29, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 29, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 5, 2021 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Jan 5, 2021 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Jan 5, 2021 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Jan 5, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 12, 2020 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Apr 13, 2019 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jun 7, 2016 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jun 7, 2016 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jun 7, 2016 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 28, 2016 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Apr 13, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 26, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 26, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 18, 2009 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 5, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 5, 2009 | ALIE | ASSIGNED TO LIE | — |
| Nov 18, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 18, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 18, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 18, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 18, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 6, 2009 | FAXX | FAX RECEIVED | — |
| Nov 4, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 28, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 28, 2009 | NWAP | NEW APPLICATION ENTERED | — |